“Knocking on the door of the ASX 100”: ACL makes $1.58b bid for healthcare giant Healius

 Australian Clinical Labs (ASX: ACL) has lobbed a $1.58 billion off-market offer to merge with one of its biggest competitors, Healius (ASX: HLS), as it looks to become the nation's largest pathology services provider and secure a deal that could have it "knocking on the door of the ASX 100". 

While ACL is the smaller of the two - with a market capitalisation of $726.6 million prior to its proposal - the Melbourne-based player believes it can help its larger rival turn around its operations, which posted a net profit loss of $28.7 million and earnings loss of $13.2 million in 1HFY23.

If the deal goes through, the combined entity will have 171 labs and 3,413 collection centres across the country, with expectations they will save up to $95 million over the next four years under the proposed combination of their labs, logistics, procurement benefits, back-office activities and overlapping IT systems.

Read More: https://www.businessnewsaustralia.com/articles/australian-clinical-labs-makes-1-5b-bid-for-healthcare-giant-healius.html



Comments

Popular posts from this blog

HOW TO FORMALLY CLOSE AND SELL BUSINESS IN 7 STEPS

How to Buy An Existing Business for Sale in Perth?

Finbar Group completes AT238 tower, ramps up $677m in projects amid Perth’s housing crisis